(Q34734156)

4 August 2017

1 reference

title

New agents for the treatment of renal cell carcinoma (English)

1 reference

4 August 2017

Tian GG

1

1 reference

4 August 2017

Dawson NA

series ordinal

2

1 reference

4 August 2017

language of work or name

1 reference

1 December 2001

1 reference

Expert Review of Anticancer Therapy

4 August 2017

published in

1 reference

4 August 2017

volume

1

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

546-554

1 reference

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.4.546

Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.4.546

Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.4.546

Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.4.546

VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.4.546

21 January 2018

Identifiers

DOI

10.1586/14737140.1.4.546

1 reference

release_d3qey6mlwngwtin4434n6ifjc4

4 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d3qey6mlwngwtin4434n6ifjc4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference